Latest Form 4 insider transactions

Roberto R Herencia, CHIEF EXECUTIVE OFFICER and a Director of Byline Bancorp, Inc., sold 19,750 shares of common stock on August 13, 2026 for $39.21 per share.

John R Prann Jr, a Director of CoreCivic, Inc., sold 30,000 shares of common stock on August 14, 2026 for $32.21 per share.

Anthony L Grande, EVP, Chief Development Officer of CoreCivic, Inc., sold 801 shares of common stock on August 13, 2026 for $34.00 per share.

Howard T Slayen, a Director of Aehr Test Systems, sold 5,700 shares of common stock on August 14, 2026 for $133.03 per share.

Didier H. Lasserre, a Director of Gsi Technology Inc, received 40,000 shares of common stock on August 13, 2026.

Paul T Quinlan, General Counsel of Oruka Therapeutics, Inc., sold 52,000 shares of common stock on August 14, 2026.

Harley G. Lappin, a Director of CoreCivic, Inc., sold 25,032 shares of common stock on August 13, 2026.

Joseph Keough, a Director of Interface Inc, reported a transaction in 8,442 shares of common stock on August 13, 2026.

Teresa Deluca, a Director of LifeStance Health Group, Inc., sold 20,441 shares of common stock on August 13, 2026 for $12.23 per share.

Barbara Trebbi, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Velchamy Sankarlingam, Pres. of Engineering & Product of Zoom Communications, Inc., sold 7,644 shares of common stock on July 15, 2026 for $91.98 per share.

Sam Levinson, a Director and 10% owner of Clipper Realty Inc., purchased 154,764 shares of common stock on August 12, 2026.

Rhea J Posedel, a Director of Aehr Test Systems, sold 5,973 shares of common stock on August 14, 2026 for $140.00 per share.

Peter M Castleman, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Third Rock Ventures V, L.P. and 5 others reported changes in beneficial ownership of Septerna, Inc. common stock on August 12, 2026.

T Danny Phillips, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Arjun Agarwal, Senior Vice President, Finance of Oruka Therapeutics, Inc., sold 10,000 shares of common stock on August 13, 2026.

Lloyd Minor, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Joseph E Gilliam, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Sachin Jain, Chief Operating Officer of CoreWeave, Inc., sold 1 shares of common stock on August 12, 2026 for $110.00 per share.

David Paul Fredrickson, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Jeff L Vacirca, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Laura I Johansen, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

Brian Charles Shackley, SVP, Chief Accounting Officer of AeroVironment Inc, sold 205 shares of common stock on August 14, 2026 for $201.86 per share.

Jon Halbert, a Director of Caris Life Sciences, Inc., received 13,192 shares of common stock on August 14, 2026.

AJB Investment Fund II, LP and 3 others reported changes in beneficial ownership of Jewett Cameron Trading Co Ltd common stock on August 12, 2026.

Laurence E Paul, a Director of Bausch & Lomb Corp, received 11,776 shares of common stock on August 12, 2026.

Ping Tak Wu, VP, U.S. Operations of Gsi Technology Inc, received 30,000 shares of common stock on August 13, 2026.

Matthew Kalish, a Director of DraftKings Inc., reported multiple transactions in common stock on August 12, 2026.

Trecia M Canty, SVP and General Counsel of PBF Energy Inc., sold 140,320 shares of common stock on August 12, 2026.